Why the study?
Mechanisms relevant to excessive deposition of extracellular matrix in cardiac fibrosis remain to be uncovered.
TRIM72 promotes cardiac fibrosis and fibroblast-to-myofibroblast transition via the STAT3/Notch-1 pathway, highlighting a potential novel therapeutic target for cardiac remodeling.
No takes yet. Share an insight, caveat, or question.
TRIM72 silencing attenuates fibrosis in TAC mice; hypothesis-generating for human cardiac remodeling therapies.
Chen et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: